###begin article-title 0
###xml 92 98 <span type="species:ncbi:9606">Humans</span>
###xml 103 107 <span type="species:ncbi:10090">Mice</span>
Growth of Peripheral and Central Nervous System Tumors Is Supported by Cytoplasmic c-Fos in Humans and Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: DCS GAG NT BLC. Performed the experiments: DCS GAG NT DFB. Analyzed the data: DCS GAG NT DFB BLC. Contributed reagents/materials/analysis tools: BLC. Wrote the paper: DCS BLC.
###end p 1
###begin p 2
Current address: CEA/DSV/iRCM/SCSR, Laboratoire de RadioPathologie, Fontenay aux Roses, France
###end p 2
###begin p 3
Current address: The Research Scripps Institute, Jupiter, Florida, United States of America
###end p 3
###begin p 4
Current address: Facultad de Ciencias de la Salud, Instituto de Patologia Experimental, Universidad Nacional de Salta, Salta, Argentina
###end p 4
###begin p 5
Current address: Departamento de Farmacologia, Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Cordoba, Argentina
###end p 5
###begin title 6
Background
###end title 6
###begin p 7
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 300 305 <span type="species:ncbi:9606">human</span>
We have previously shown that the transcription factor c-Fos is also capable of associating to endoplasmic reticulum membranes (ER) and activating phospholipid synthesis. Herein we examined phospholipid synthesis status in brain tumors from human patients and from NPcis mice, an animal model of the human disease Neurofibromatosis Type 1 (NF1).
###end p 7
###begin title 8
Principal Findings
###end title 8
###begin p 9
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 330 337 <span type="species:ncbi:9606">patient</span>
In human samples, c-Fos expression was at the limit of detection in non-pathological specimens, but was abundantly expressed associated to ER membranes in tumor cells. This was also observed in CNS of adult tumor-bearing NPcis mice but not in NPcis fos(-/-) KO mice. A glioblastoma multiforme and a malignant PNS tumor from a NF1 patient (MPNST) showed a 2- and 4- fold c-Fos-dependent phospholipid synthesis activation, respectively. MPNST samples also showed increased cell proliferation rates and abundant c-Fos expression.
###end p 9
###begin title 10
Conclusions
###end title 10
###begin p 11
Results highlight a role of cytoplasmic c-Fos as an activator of phospholipid synthesis in events demanding high rates of membrane biogenesis as occurs for the exacerbated growth of tumors cells. They also disclose this protein as a potential target for controlling tumor growth in the nervous system.
###end p 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Angel1">[1]</xref>
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Caputto1">[3]</xref>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">jun</italic>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Angel1">[1]</xref>
###xml 360 363 360 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Kouzarides1">[4]</xref>
The expression of c-Fos is tightly regulated responding rapidly and transiently to a plethora of stimuli [1]-[3]. c-Fos heterodimerizes with proteins of the jun family to form some of the many AP-1 transcription factors that regulate the expression of target genes such as those involved in the initiation of DNA synthesis as a response to growth factors [1], [4]. However, understanding the participation of AP-1 in complex processes such as those of multi-step tumorigenesis has not yet been completely achieved.
###end p 13
###begin p 14
###xml 286 289 286 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Guido1">[5]</xref>
###xml 291 294 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Bussolino1">[6]</xref>
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Bussolino2">[7]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Gil1">[8]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
We have shown that, in addition to its nuclear activity, c-Fos associates to membranes of the endoplasmic reticulum (ER), the main site of phospholipid production, and activates their synthesis. This has been observed in light stimulated retina ganglion and photoreceptor cells in vivo [5], [6], in NIH 3T3 cells induced to re-enter growth [7] and in PC12 cells induced to differentiate [8], [9].
###end p 14
###begin p 15
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Portal1">[10]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Portal1">[10]</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
In actively growing and proliferating T98G cells, a human glioblastoma multiforme-derived cell line, it is observed abundant ER-associated c-Fos expression and c-Fos-dependent phospholipid synthesis activation, both of which are reversibly inhibited upon phosphorylation of c-Fos tyrosine residues [10]. Phosphorylation of c-Fos tyrosine residues was also observed in NIH 3T3 fibroblasts [10]. We hypothesized from these results that in cells committed to grow and/or proliferate, activation of lipid synthesis by c-Fos is crucial for enabling the endomembrane system to supply the massive demands of membrane to sustain these processes.
###end p 15
###begin p 16
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:10090">mouse</span>
###xml 294 299 <span type="species:ncbi:9606">human</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
In the search for experimental paradigms including the complex environment in which in vivo tumor development occurs, herein we examined the status of cytoplasmic c-Fos expression and phospholipid synthesis activation in malignant human brain tumors, in the NPcis mouse -an animal model of the human disease Neurofibromatosis Type I- and also in NPcis mice KO for c-Fos. Results show that high rates of proliferation are tightly coupled to an elevated expression of ER-associated c-Fos together with activated rates of phospholipid synthesis.
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
###xml 10 15 <span type="species:ncbi:9606">Human</span>
Malignant Human Brain Tumors Show Abundant Cytoplasmic c-Fos and Activated Phospholipid Synthesis
###end title 18
###begin p 19
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Portal1">[10]</xref>
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g001">Fig. 1A</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g001">Fig. 1B</xref>
###xml 740 747 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g001">Fig. 1A</xref>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 633 638 <span type="species:ncbi:9606">human</span>
Since previous results in T98G cells indicate an association of cytoplasmic c-Fos expression with tumor cell proliferation and growth [10], this was examined in an array of 156 human brain tumors and 17 non-pathological tissue samples. Representative samples in Fig. 1A show abundant cytoplasmic c-Fos expression in all tumor specimens examined that included glioblastoma multiforme (GM) (n = 101), medulloblastomas (n = 15), ependymomas (n = 7) and astrocytomas (n = 33). c-Fos/ER co-localization was also found in all specimens whereas only 25% of them were positive for nuclear c-Fos (Fig. 1B). By contrast, the examination of 17 human non-pathological brain specimens showed c-Fos and the ER marker calnexin near their detection limit (Fig. 1A, 4th row).
###end p 19
###begin title 20
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human brain tumors show abundant c-Fos expression co-localizing with the ER marker calnexin.
###end title 20
###begin p 21
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 501 502 501 502 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
(A) Expression of c-Fos, the ER marker calnexin, and the nuclear marker of proliferating cells PCNA in human brain tumor specimens (n = 156) and non-pathological samples (n = 17). Representative samples of astrocytoma (1st row), GM (2nd row), medulloblastoma (3rd row) and human brain non-pathological samples (4th row) from a tissue array immunostained for c-Fos (red) and calnexin (green); 3rd column is the merge of the previous two columns. Yellow color evidences c-Fos/ER co-localization sites. (B) Immunostaining for c-Fos (red), PCNA (green) and the merged image of both is shown for an astrocytoma (1st row), a GM (2nd row) and a medulloblastoma (3rd row). Arrows: proliferating cells with nuclear c-Fos; arrowheads: cells showing predominantly peri-nuclear c-Fos. Bar: 20 microm. Fourth column in A and B is a 20x magnification of the boxed area in the 3rd column.
###end p 21
###begin p 22
###xml 298 306 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 561 567 561 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g002">Fig. 2</xref>
###xml 950 956 950 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g002">Fig. 2</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 1018 1023 <span type="species:ncbi:9606">human</span>
c-Fos content and phospholipid synthesis activation were also examined in total homogenate (TH) and in microsomal fraction (MF) prepared from a non-fixed human GM and in a paired non-pathological sample (excised during surgery for tumor extirpation). Phospholipid synthesis capacity was determined in vitro in TH, in MF and in 1M-KCl-stripped MF prepared from these paired specimens. Phospholipid synthesis was activated only in the c-Fos-containing fractions prepared from the GM (TH and MF) but disappeared after stripping MF of associated proteins with KCl (Fig. 2). The decrease in phospholipid synthesis in KCl-stripped tumor MF was restored to initial levels by adding c-Fos to the assay medium. Phospholipid synthesis activation was also observed in the non-pathological MF upon c-Fos addition. WB examination showed abundant c-Fos expression in the GM in comparison with the non-pathological specimen which was at its detection limit (inset, Fig. 2). Similar results were obtained with 12 additional non-fixed human malignant brain tumors that included: GM (n = 9), medulloblastomas (n = 1) and astrocytomas (n = 3) (not shown).
###end p 22
###begin title 23
###xml 73 78 <span type="species:ncbi:9606">human</span>
Phospholipid synthesis is activated in c-Fos-containing membranes from a human GM.
###end title 23
###begin p 24
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 70 77 <span type="species:ncbi:9606">patient</span>
A human GM and adjacent non pathological tissue excised from the same patient were used to prepare total homogenate (TH), microsomal membrane fraction (MF), 1M KCl-stripped microsomal membrane fraction (MF+KCl) and stripped MF plus 1 ng of c-Fos/microg of TH (MF+KCl+c-Fos) and assayed for phospholipid synthesis capacity. Results are the mean % +/- SD of 3 experiments performed in triplicate; non-pathological TH values were taken as 100%. Inset: WB for c-Fos content in the samples assayed; Tubulin staining is used as a loading control. NP: non-pathological; GM: glioblastoma multiforme.
###end p 24
###begin p 25
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Silvestre1">[11]</xref>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009544.s001">Fig. S1</xref>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
The low immunolabeling observed for calnexin in non-pathological samples is in accordance with previous observations in which the content and concentration of ER membrane markers were found to correlate with the proliferative status of brain tissue: at early developmental stages, actively growing and dividing cells demand elevated rates of membrane biogenesis and show abundant expression of ER resident proteins and a significantly higher content of ER membranes which decreases as development proceeds. In mouse brain, c-Fos expression shows a similar pattern during development: it is high and co-localizes with the ER markers in the embryo whereas in the adult, immunostaining of both is practically undetectable ([11] and Fig. S1).
###end p 25
###begin p 26
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Moenner1">[12]</xref>
Deregulation of the ER homeostasis has been correlated with cancer in many instances [12]. Having found herein that the expression of both c-Fos and ER markers are significantly higher in tumor samples as compared to non-pathological tissue and that c-Fos is associated to the ER in all cases gives support to the need of ER-associated c-Fos for the progression of CNS tumors.
###end p 26
###begin title 27
###xml 6 10 <span type="species:ncbi:10090">Mice</span>
NPcis Mice Tumors Show High Levels of c-Fos Expression
###end title 27
###begin p 28
###xml 101 108 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
Given the results described above, the relevance of cytoplasmic c-Fos for tumor growth was validated in vivo in the animal model of the human syndrome Neurofibromatosis Type I (NF1), the NPcis mouse, which allows the follow-up of tumor progression with respect to c-Fos expression.
###end p 28
###begin p 29
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nf1</italic>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Guha1">[13]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Serra1">[14]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Cichowski1">[15]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Ferner1">[16]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Rasmussen1">[17]</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 863 871 <span type="species:ncbi:9606">patients</span>
Patients suffering of NF1 are born with one mutated allele of the nf1 gene which encodes for neurofibromin, a member of the Ras-GAP family that is particularly expressed in the CNS and PNS. As this mutated allele is non-functional, the subsequent inactivation of the remaining functional allele on a given cell type is sufficient to promote tumor formation [13], [14]. The primary clinical feature of NF1 is the development of benign peripheral nerve sheath tumors termed neurofibromas [15], which are composed primarily of neoplastic Schwann cells and non-neoplastic stromal cells. Dermal neurofibromas are benign and associated with a single nerve whereas diffuse neurofibromas involve many fascicles and are susceptible to become malignant, in which case they are denominated Malignant Peripheral Nerve Sheath Tumors (MPNST's) [16]. Between 15% and 50% of NF1 patients develop some type of glioma, although they are often indolent in nature [17].
###end p 29
###begin p 30
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trp</italic>
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nf1</italic>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Reilly1">[18]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Cichowski2">[19]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Costa1">[20]</xref>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Reilly1">[18]</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 629 635 <span type="species:ncbi:9606">humans</span>
NPcis mice bare, on a C57BL/6J background, a disrupted allele of both the trp53 and the nf1 tumor suppressor genes that are located on chromosome 11 at 7 cM of distance from each other. Consequently, both genes usually segregate together. Loss of heterozygosis determines the spontaneous development of CNS and PNS tumors with a penetrance close to 100% by the age of 6-7 months [18]. The histological pattern of the CNS tumors resembles that of GM whereas the PNS tumors show the histological characteristics of human MPNST's [19], [20]. These animals have been proposed as a good model to study secondary glioblastomas that in humans progress from lower grades of astrocytomas involving loss of TP53 [18].
###end p 30
###begin p 31
###xml 261 280 261 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g003">Fig. 3A, left panel</xref>
###xml 364 384 364 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g003">Fig. 3A, right panel</xref>
###xml 530 537 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g003">Fig. 3B</xref>
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Zhu1">[21]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Zhu2">[22]</xref>
###xml 778 785 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g003">Fig. 3C</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
c-Fos expression was examined in CNS and PNS tumors from 6-month-old NPcis mice with clear signs of PNS tumor burden and compared to littermate C57BL/6J wild type (WT) animals. As expected, high levels of c-Fos were observed in brain cortex from NPcis animals (Fig. 3A, left panel) contrasting with the lack of expression in the same area of their WT littermates (Fig. 3A, right panel). PNS tumor samples also clearly show abundant c-Fos and the proliferation marker PCNA immunostaining with a histology resembling Schwann cells (Fig. 3B). Schwann cells are thought to be the initiation site of peripheral tumor malignancy in the course of disease development [21], [22]. As expected, c-Fos immunostaining was found colocalizing with the ER marker calnexin in these PNS tumors (Fig. 3C).
###end p 31
###begin title 32
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Expression and subcellular localization of c-Fos in CNS and PNS tumors from NPcis mice.
###end title 32
###begin p 33
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 275 276 275 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 366 367 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
(A) c-Fos expression was determined in mouse brain cortex from a tumor-bearing NPcis mouse (left) and a WT littermate (right) by staining with DAB-peroxidase. Note the abundant c-Fos expression in the NPcis sample, contrasting with the undetectable levels in the WT animal. (B) c-Fos (left) and PCNA (right) expression in peripheral nerve tumors stained as in (A). (C) Confocal immunofluorescence analysis of peripheral nerve tumors evidencing abundant c-Fos (red) and the ER marker Calnexin (green) immunolabeling. The merged image at right clearly shows c-Fos/ER co-localization. Three additional animals showed the same results as in (A), (B) and (C). Inset: magnification of the box delimited area. Bar: 20 microm.
###end p 33
###begin title 34
Adult NPcis Brain Show High Levels of c-Fos Expression as Compared to WT Animals
###end title 34
###begin p 35
###xml 249 255 249 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g004">Fig. 4</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Smeyne1">[23]</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Penner1">[24]</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
To correlate c-Fos expression levels with abnormal proliferation in adult NPcis brain, the content of c-Fos, determined by WB, in brain TH from NPcis mice was compared with that from their C57BL/6J WT littermates at the indicated times after birth (Fig. 4). As expected, at 1 month of age, detectable levels of c-Fos were found both in NPcis and WT brain samples which, in the latter case, decreased with age [23], [24]. By contrast, in the NPcis samples both at 2 and 3 months of age, c-Fos content remained at the levels found at 1 month or even tended to increase. These high levels of c-Fos expression observed in the NPcis animals at ages in which in WT mice proliferation has ceased and c-Fos expression declined, point to the persistence of a proliferative condition of the NPcis brain even prior to noticeable PNS tumor manifestation.
###end p 35
###begin title 36
###xml 42 46 <span type="species:ncbi:10090">mice</span>
c-Fos expression in NPcis and C57BL/6J WT mice brain according to age and to the proliferative status of the tissue.
###end title 36
###begin p 37
###xml 73 77 <span type="species:ncbi:10090">mice</span>
c-Fos content was determined by WB in brain homogenate from NPcis and WT mice at the ages indicated (upper panel). Tubulin was used as a loading control (lower panel). Results shown are from one representative experiment out of two performed.
###end p 37
###begin title 38
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
In Vivo Blocking of c-Fos Expression Blocks Cell Proliferation
###end title 38
###begin p 39
We next studied the dependence of proliferation in the CNS on c-Fos expression. For this, 4-month-old tumor bearing-NPcis animals were treated with a c-Fos mRNA antisense oligonucleotide (ASO), the corresponding sense (or scrambled) oligo (SO) or vehicle infused intra-cranially by means of a subcutaneously implanted osmotic pump which was connected to a cannula inserted in the caudate putamen (CP) to constantly deliver treatment solution during 28 days. The area of CP to which the pumps dispensed the treatment solution was delimited by loading pumps with 0.5% w/v methylene blue and infusing as in the experimental animals.
###end p 39
###begin p 40
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5A</xref>
###xml 703 710 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5A</xref>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
Fig. 5A shows the expression levels of c-Fos and of the proliferation marker PCNA in CP determined by WB. The first 2 lanes correspond to the same NPcis animal in which the left hemisphere did not receive c-Fos ASO (NPcis-ASO) whereas the right hemisphere did (NPcis+ASO); the 3rd and 4th lanes correspond to CP from NPcis animals treated with sense oligo (NPcis+SO) or vehicle (NPcis+vehicle) respectively, whereas the 5th lane shows CP from a non-treated NPcis mouse. These results once again highlight the need of c-Fos expression for proliferation as specifically blocking it also blocks cell proliferation of tumor cells as indicated by PCNA expression (compare the 2nd lane with all other ones of Fig. 5A).
###end p 40
###begin title 41
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Phospholipid synthesis activation and AP-1 content in NPcis mice brain as compared to C57BL/6J WT or fos (-/-) KO mice.
###end title 41
###begin p 42
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 181 202 181 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 785 786 785 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 824 832 824 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1167 1170 1167 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 1361 1362 1359 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1370 1371 1368 1369 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1773 1776 1771 1774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 497 502 <span type="species:ncbi:10090">mouse</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 678 683 <span type="species:ncbi:10090">mouse</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
###xml 1180 1184 <span type="species:ncbi:10090">mice</span>
###xml 1326 1330 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
###xml 1603 1608 <span type="species:ncbi:10090">mouse</span>
###xml 1726 1731 <span type="species:ncbi:10090">mouse</span>
###xml 1785 1790 <span type="species:ncbi:10090">mouse</span>
###xml 1817 1822 <span type="species:ncbi:10090">mouse</span>
###xml 1858 1863 <span type="species:ncbi:10090">mouse</span>
(A) NPcis mice at 4 months of age showing clear PNS tumor burden were treated during 28 days with ASO, SO or vehicle dispensed by an osmotic pump into the caudate putamen (CP) (see Materials and Methods). After treatment, animals were sacrificed and CP examined by WB for c-Fos and PCNA expression, the latter as an indication of the proliferative status of the tissue. The first two lanes correspond to CP from the left (non-treated) and right (ASO-treated) brain hemispheres from the same NPcis mouse. The 3rd and 4th lanes correspond to the CP from the right, SO-treated or vehicle-treated hemisphere from NPcis mice. The last lane corresponds to CP from a non-treated NPcis mouse. One experiment representative of two performed is shown. Tubulin was stained as a loading control. (B) Phospholipid synthesis was measured in vitro in CP from NPcis mice non-treated (1st column), or treated during 28 days as indicated in (A) with SO (2nd column) or from NPcis mice treated only in the right hemisphere with ASO (3rd column, NPcis+ASO) and compared to CP from the left hemisphere of the ASO-treated animals (4th column, NPcis -ASO) or to WT (5th column) or C57BL/6J fos (-/-) KO mice (last column), as indicated. Results are the mean +/- SD of two independent experiments performed in triplicate; *p<0.005 with respect to WT mice as determined using Student's t test. (C) EMSA determination of total AP-1 content in nuclear fractions prepared from CP of mice treated as stated in (A). The first two lanes correspond to the left, non-treated and right, ASO-treated brain hemispheres from the same NPcis mouse. The 4th and 5th lanes correspond to the left, vehicle-treated and right, SO-treated hemispheres from the same NPcis mouse. The last 3 lanes correspond to C57BL/6J fos(-/-) KO mouse (7th lane), a C57BL/6J WT mouse (8th lane) and a non-treated NPcis mouse (last lane). Lanes marked with (C) were competed with 100X unlabeled AP-1 probe (3rd and 6th lanes) to establish binding specificity. Results are from one of three experiments performed with the same results.
###end p 42
###begin title 43
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
In Vivo Blocking of c-Fos Expression Abrogates Phospholipid Synthesis Activation without Affecting AP1 Content
###end title 43
###begin p 44
###xml 131 134 131 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Angel1">[1]</xref>
###xml 491 499 491 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 667 674 667 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5A</xref>
###xml 758 761 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
The transcriptional AP-1 activity of c-Fos has been exhaustively examined and its importance in cell proliferation well documented [1]. Consequently, it was deemed of importance to determine the relevance of both activities of c-Fos in supporting proliferation and growth of tumors: its participation in the formation of AP-1 transcription factors and its phospholipid synthesis activation capacity. To address this point, both AP-1 content and phospholipid synthesis capacity were examined in vitro in CP excised from 7-month-old tumor bearing-NPcis animals expressing high amounts of c-Fos (non-treated NPcis or treated with SO intra-cranially during 28 days as in Fig. 5A) or having low/null content of c-Fos (treated intra-cranially with ASO or C57BL/6J fos KO mice), and in untreated C57BL/6J WT animals.
###end p 44
###begin p 45
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5B</xref>
###xml 126 133 126 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5A</xref>
###xml 557 560 557 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 590 597 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5B</xref>
###xml 650 657 650 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5B</xref>
###xml 690 696 690 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g004">Fig. 4</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
Fig. 5B shows the phospholipid synthesis capacity in CP from non-treated NPcis mice (NPcis), or from NPcis mice treated as in Fig. 5A with SO (NPcis+SO) or ASO (NPcis+ASO) dispensed into the right hemisphere; NPcis-ASO corresponds to the non-treated left hemisphere of the ASO-treated animals. Clearly, blocking the expression of c-Fos with ASO abrogates phospholipid synthesis activation to similar rates as those found in WT animals (C57BL/6J WT) whereas SO has no effect. For comparative purposes, the phospholipid synthesis capacity of CP from C57BL/6J fos KO mice was also determined (Fig. 5B, last column) and found similar to that of WT mice (Fig. 5B, 5th column) which, as shown in Fig. 4, contain undetectable levels of c-Fos.
###end p 45
###begin p 46
###xml 230 237 230 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5B</xref>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 572 579 572 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5C</xref>
###xml 657 664 657 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5C</xref>
###xml 828 835 828 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5B</xref>
###xml 1003 1010 1003 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g005">Fig. 5C</xref>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
Next, we determined if blocking c-Fos expression affects the bulk content of AP-1 transcription factor dimers by electrophoresis mobility shift assays (EMSA) performed with nuclear extracts prepared from the brain samples used in Fig. 5B. Interestingly, no significant differences were observed in the AP-1 content of any of the different experimental conditions examined, that is, in those containing abundant c-Fos (lanes 1, 3 and 4) or those lacking appreciable amounts of c-Fos as is the case of the NPcis+ASO mice (lane 2), C57BL/6J WT or fos KO mice (lanes 7 and 8)(Fig. 5C). It is interesting to note that the results shown in the first two lanes of Fig. 5C (NPcis-ASO and NPcis+ASO) correspond to the left and right hemispheres of the same NPcis animals that were treated with ASO only in the right one and, as shown in Fig. 5B, differ significantly in their capacity to activate phospholipid synthesis that is tightly correlated to their c-Fos content but not in their AP-1 content as shown in Fig. 5C.
###end p 46
###begin p 47
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
That the total levels of AP-1 result roughly constant irrespective of the presence or absence of c-Fos (including that in the fos KO mice) points to the presence of other, c-Fos-devoid, AP-1 dimers. Taken together, these results highlight the capacity of c-Fos to activate phospholipid synthesis as relevant to sustain proliferation and growth of adult brain tumor cells.
###end p 47
###begin title 48
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 16 20 <span type="species:ncbi:10090">Mice</span>
NPcis fos (-/-) Mice Show No PNS Tumors
###end title 48
###begin p 49
###xml 180 201 180 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Johnson1">[25]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Wang1">[26]</xref>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 517 520 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
To further examine the importance of c-Fos expression for the generation of PNS tumors in NPcis mice, NPcis mice with germline disruptions on both c-Fos alleles were obtained (see Materials and Methods) and PNS tumor incidence examined. C57BL/6J fos(-/-) mice, although viable, die at approximately 7 months of age, are infertile and growth-retarded respect to their WT littermates [25], [26]. NPcis, fos(-/-) animals displayed these phenotypes, whereas NPcis, fos(+/-) were found indistinguishable from their NPcis, fos(+/+) counterpart mice.
###end p 49
###begin p 50
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009544-t001">Table 1</xref>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Reilly1">[18]</xref>
###xml 563 566 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 821 824 821 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
Peripheral tumor incidence was determined in NPcis, fos(-/-) mice at the time of their death and compared to their NPcis, fos(+/+) or (+/-) littermates. Table 1 shows that PNS tumor formation was not observed in any of the NPcis, fos(-/-) mice born from independent mothers whereas the NPcis, fos(+/+) or fos(+/-) animals developed neurofibromas with an incidence similar to that observed previously [18] at the ages considered in each case (mean incidence of 71.4% animals with tumor burden at the age of 4-5 months contrasting with 0% incidence in their NPcis, fos(-/-) littermates). So, no PNS tumor development could be observed when c-Fos expression is intrinsically impeded by interrupting its gene in the NPcis mice whereas no differences were observed in tumor formation penetrance between the NPcis fos(+/+) and fos(-/+) mice.
###end p 50
###begin title 51
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
NPcis, fos(-/-) mice do not generate tumors.
###end title 51
###begin p 52
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 399 402 399 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Tumor burden in all NPcis littermates was determined (or confirmed in the case detection was prior to sacrifice) at the time of death of the NPcis, fos(-/-) mice. No differences were observed in tumor burden between NPcis, fos(+/+) and NPcis, fos(+/-) mice which were pooled as a single group and compared to their NPcis, fos(-/-) littermate. Mean tumor incidence in the NPcis, fos(+/+) plus NPcis, fos(+/-) animals was 71.4% (n = 13) contrasting with the 0% (n = 6) found in the NPcis, fos(-/-) group.
###end p 52
###begin p 53
*v.a.s.: verified at sacrifice.
###end p 53
###begin title 54
###xml 22 27 <span type="species:ncbi:9606">Human</span>
c-Fos Expression in a Human PNS Tumor
###end title 54
###begin p 55
###xml 193 202 193 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g006">Figure 6A</xref>
###xml 486 493 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g006">Fig. 6B</xref>
###xml 753 761 753 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 864 871 864 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g006">Fig. 6C</xref>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 75 82 <span type="species:ncbi:9606">patient</span>
We next examined the presence of c-Fos in a MPNST excised from a human NF1 patient and in normal tissue excised adjacent to this tumor. The histological features of each sample are depicted on Figure 6A in which the presence of malignant-neoplastic cells are clearly observed in the transformed tissue respect to the non transformed one. Both c-Fos and PCNA expression are abundant in the MPNST contrasting with the non-detectable levels of these proteins observed in the normal nerve (Fig. 6B). Again, c-Fos expression appears tightly correlated with the proliferative state of the tissue: it is not detectable or absent in normal tissue and up-regulated in the tumor one. Finally, the capacity of both samples to synthesize phospholipids was measured in vitro. As expected, TH phospholipid synthesis was >4-fold higher in the MPNST respect to the normal sample (Fig. 6C).
###end p 55
###begin title 56
###xml 87 94 <span type="species:ncbi:9606">patient</span>
c-Fos expression is abundant and phospholipid synthesis is activated in a MPNST from a patient with NF1 syndrome.
###end title 56
###begin p 57
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 224 225 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 388 389 388 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
(A) Histological examination of a MPNST and a non-pathological specimen excised from an NF1patient, stained with haematoxylin/eosin. Note the neoplastic cells in the MPNST contrasting with the non-pathological (NP) tissue. (B) WB for c-Fos and PCNA of the samples shown in (A). Note the lack of c-Fos and PCNA expression in the normal tissue (NP). Tubulin was used as a loading control. (C) Phospholipid synthesis capacity in TH from the MPNST and the NP sample. Results are the mean % +/- SD of 2 experiments performed in triplicate. TH values from NP were taken as 100%. Phospholipid synthesis activity in the MPNST was >4-fold that in NP; *p<0.005.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Gil1">[8]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Portal1">[10]</xref>
Previous results disclosed a dual function of c-Fos that is topologically and temporarily separable: it first releases the genomic program for nuclear control of cell growth and then sustains it via its cytoplasmic association to the ER and activation of phospholipid synthesis [8], [10]. Since the above mentioned results were obtained from cells in culture, the role of c-Fos as a stimulator of membrane biogenesis in events associated to cell growth an proliferation must necessarily be confronted with results obtained using experimental paradigms that include the complex environment in which in vivo tumor development occurs.
###end p 59
###begin p 60
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
Examination of an array of human brain tumors consistently showed abundant cytoplasmic, ER-associated c-Fos expression. Moreover, microsomal membranes from non fixed human malignant brain tumors showed activated phospholipid synthesis; this capacity was lost upon removal of c-Fos by washing with 1M KCl, but was recovered upon addition of recombinant c-Fos. Similar results were found in a MPNST in which abundant c-Fos expression together with a more than 4-fold increase in phospholipid synthesis activity was observed when compared to non-pathological tissue.
###end p 60
###begin p 61
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 539 546 539 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 735 740 <span type="species:ncbi:9606">human</span>
Tumor growth dependence on cytoplasmic c-Fos expression was further confirmed in tumor-bearing NPcis mice which consistently show elevated expression of ER-associated c-Fos in brain cortex and in proliferating cells of PNS and CNS tumors. c-Fos antisense oligonucleotide infused intra-cranially reduced c-Fos expression and cell proliferation. Moreover, no tumor development occurred in NPcis fos(-/-) mice in spite of the fairly conserved levels of AP-1 content in brain tissue from all animals irrespective of their c-Fos content. Thus, in vivo results in this model disclose the dependence of CNS and PNS tumor growth on cytoplasmic c-Fos expression and phospholipid synthesis activation. Also, compared to non-pathological tissue, human brain tumors evidenced abundant ER-associated c-Fos expression, and more than 2-fold activated phospholipid synthesis.
###end p 61
###begin p 62
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Johnson1">[25]</xref>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Angel1">[1]</xref>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Kouzarides1">[4]</xref>
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 738 741 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Fleischmann1">[27]</xref>
###xml 911 914 911 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Gil1">[8]</xref>
###xml 916 919 916 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
###xml 1328 1331 1328 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 1504 1508 1504 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Fleischmann1">[27]</xref>
###xml 1664 1668 1664 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos(</italic>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 1371 1375 <span type="species:ncbi:10090">mice</span>
###xml 1673 1677 <span type="species:ncbi:10090">mice</span>
Diverse studies have suggested that, as a transcription factor, c-Fos is indispensable for proliferation. However, homozygous fos(-/-) mice are viable, morphologically normal but grow to a smaller final size than their counterpart WT or fos(+/-) animals [25]. This poses the question of why mitogenic stimulation of cells results so effective in inducing the expression of c-fos[1], [4] and yet c-Fos absence affects animal size rather than cell proliferation. Noteworthy is the observation that in these fos(-/-) mice another component of the AP-1 family, Fra-1, rescues c-Fos functions in the growth process when its expression is controlled by the c-Fos promoter but fails to substitute c-Fos in inducing expression of target genes in fos(-/-) fibroblasts [27]. Interestingly, the basic domain of c-Fos (BD that comprises amino acids 139-159), which is essential to achieve phospholipid synthesis activation [8], [9] is highly homologous to the BD of Fra-1, differing only in two conservative amino acid substitutions. This predicts the BD of Fra-1 as capable of activating phospholipid synthesis when Fra-1 is expressed and should, in consequence, support normal growth rates. Preliminary data from our laboratory have shown that this is indeed so (G Castro & BL Caputto, unpublished data). However, this is not the case in fos(-/-) animals probably because as in WT mice, only very small overlapping expression patterns of these proteins is observed when each gene is controlled by its own promoter [27]. So, even if AP-1 c-Fos may trigger the genomic events required for proliferation and growth, this activity must be exerted by other AP-1 complexes in the fos(-/-) mice.
###end p 62
###begin p 63
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Hanahan1">[28]</xref>
###xml 591 594 591 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-deArribaZerpa1">[29]</xref>
###xml 975 978 975 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Borioli1">[30]</xref>
###xml 1165 1168 1165 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
###xml 1230 1231 1230 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1356 1359 1356 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Gil1">[8]</xref>
###xml 1361 1364 1361 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
###xml 1500 1504 1500 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Portal1">[10]</xref>
###xml 1525 1526 1525 1526 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
At present there is abundant information about genomic events that underlie uncontrolled growth of tumor cells [28]. On the contrary, reports on the pleiotropic changes that necessarily accompany cell growth and proliferation are scarce. Although the elucidation of the molecular mechanism is still in progress, c-Fos is emerging as an inducible protein capable of activating the metabolic machinery of lipid synthesis for membrane biogenesis to accompany growth. Nevertheless, it is clear that not all enzymes of a lipid pathway must be activated to attain an overall lipid activated state [9], [29]. Regarding the activation mechanism, two different mechanisms seem at first sight feasible: one is that c-Fos interacts directly with the enzymes that it activates and the other is that c-Fos interacts with other ER components modifying the microenvironment of the enzymes that leads to their activation. In fact, both possibilities have experimental data that support them [9], [30]. In either case, the association of c-Fos to ER components activates for example the enzyme Glusosylceramide synthase by increasing its Vmax without substantially modifying its Km [9]. Having found that c-Fos deletion mutants that contain the NH2-terminus up to BD of the full length protein (aa 1-159) are capable of activating lipid synthesis to similar rates as c-Fos [8], [9] and that the phosphorylation of tyrosine residues 10 and 30 precludes c-Fos/ER association and consequently lipid synthesis activation [10] suggests that the NH2-terminus participates in associating c-Fos to ER components whereas BD would promote the activation of the corresponding enzymes.
###end p 63
###begin p 64
###xml 203 206 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Guido1">[5]</xref>
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Crespo1">[9]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Cammer1">[31]</xref>
###xml 524 531 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009544.s002">Fig. S2</xref>
###xml 770 776 770 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009544-g002">Fig. 2</xref>
###xml 350 354 <span type="species:ncbi:10116">rats</span>
###xml 698 705 <span type="species:ncbi:9606">patient</span>
The data available at present allow us to hypothesize a shared activation mechanism in response to high-rate membrane biogenesis demands of cells irrespective of these demands arising from physiological [5]-[9] or pathological situations as shown herein. Furthermore, not only tumor-associated pathologies show ER-associated c-Fos: in spinal cord of rats sensitized to develop experimental allergic encephalomyelitis in which positive reactive gliosis is promoted [31], c-Fos expression is also increased and ER-associated (Fig. S2). In support of this hypothesis it should be noted that herein it is shown that the addition of c-Fos both to a non-pathological brain preparation obtained from a GM-patient as well as to the tumor sample stripped of associated proteins (Fig. 2) results in an activated rate of phospholipid synthesis.
###end p 64
###begin p 65
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Leppa1">[32]</xref>
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Chipuk1">[33]</xref>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Green1">[34]</xref>
The cytoplasmic regulatory role of c-Fos is not the only AP-1 independent activity of an early response gene. c-Jun was also shown to protect cells from apoptosis independently of its AP-1 activity [32]. More recently, an additional cytoplasmic activity for p53, another well characterized transcription factor capable of triggering apoptosis has been described [33]. Consequently, the concept that the biological activities of these proteins results from the combination of their nuclear and cytoplasmic activities is worth considering [34]. Therapies directed towards blocking phospholipid synthesis activation by blocking c-Fos expression are promising moreover if it is considered that this protein is normally down regulated in healthy nervous tissue but becomes up-regulated during and is causally related to cancer progression.
###end p 65
###begin title 66
Materials and Methods
###end title 66
###begin title 67
Animals
###end title 67
###begin p 68
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf1;Trp53 cis</italic>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Reilly1">[18]</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
Nf1;Trp53 cis (NPcis) mice were a kind gift from Tyler Jack's lab (Massachusetts Institute of Technology, USA). To maintain our animal colony, founders were bred to wild-type mice and progeny scored by PCR genotyping for both mutations on the same chromosome in cis using the primer sequences described [18].
###end p 68
###begin p 69
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Johnson1">[25]</xref>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 298 334 298 334 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGCAACTGAGAAGACTGGATAGAGCCGGC-3&#8242;</named-content>
###xml 346 379 346 379 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGAGCCCATGCTGGAGAAGGAGTCG-3&#8242;</named-content>
###xml 404 431 404 431 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCGAGGATCTCGTCGTGACC-3&#8242;</named-content>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 517 520 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 527 530 527 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 539 542 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fos</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
fos(+/-) mice from Jackson Laboratories [25] were inbred to obtain fos(-/-) animals. NPcis animals were mated to fos(+/-) mice to obtain NPcis, fos(+/-) mice which were then mated with fos(+/-) mice to obtain NPcis, fos(-/-) mice. The wild-type allele of c-fos was amplified with the primers FKO1 (5'-GAGCAACTGAGAAGACTGGATAGAGCCGGC-3') and FKO2 (5'-GGAGAGCCCATGCTGGAGAAGGAGTCG-3'); FKO2 and PN1 primers (5'-GGCGAGGATCTCGTCGTGACC-3') were for c-fos mutant allele scoring. When comparing tumor burden, only male NPcis, fos(+/+), fos(+/-) or fos(-/-) were considered to avoid gender-promoted differences. All mice were on a C57BL/6J background and grown under standard conditions.
###end p 69
###begin title 70
Phospholipid Synthesis Determination
###end title 70
###begin p 71
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Gil1">[8]</xref>
###xml 214 218 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Borioli1">[30]</xref>
###xml 344 345 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 689 690 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In vitro phospholipid synthesis capacity of tumors or sub-cellular fractions was performed as described previously [8]; when stated, recombinant His-tagged c-Fos (1 ng/microg of initial TH protein), obtained as in [30], was added suspended in 300 mM imidazole/8 M urea; control incubates contained an equal volume of vehicle. TH's prepared in H2O plus protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA) were centrifuged for 1h at 100,000xg and separated into MF and SF. For stripping of TH, prior to centrifugation, TH's were made 1M with KCl, left to stand for 10 min, centrifuged at 100,000xg for 1h to separate into MF and SF. MF was re-suspended in the initial volume of H2O plus protease inhibitor cocktail.
###end p 71
###begin p 72
###xml 262 264 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 327 331 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Guido2">[35]</xref>
Reactions were initiated by addition of 100 microg of TH, or the corresponding protein recovered in MF or stripped fractions re-suspended in incubation buffer, and stopped by addition of trichloroacetic acid - phosphotungstic acid (5%-0.5% final concentration). 32P-phospholipid labeling was quantified as described previously [35].
###end p 72
###begin title 73
Protein Quantification and Western Blot (WB) Analysis
###end title 73
###begin p 74
###xml 45 46 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 148 151 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Gil1">[8]</xref>
###xml 191 197 <span type="species:ncbi:9986">rabbit</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
10 microg of protein from tissue samples in H2O plus protease inhibitor cocktail were subjected to SDS-PAGE on 12% polyacrylamide gels as described [8]. Blocked membranes were incubated with rabbit anti c-Fos antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA dilution 1/5000), mouse DM1A mAb raised against alpha-Tubulin (Sigma-Aldrich, dilution 1/5000) or mouse anti PCNA antibody (Santa Cruz Biotechnology, dilution 1/1000), washed twice for 15 min in PBS-Tween and incubated with secondary biotin-conjugated antibody (Vector Laboratories, Burlingame, CA, USA, dilution 1/15000) raised against each corresponding primary antibody followed by incubation with streptavidin-peroxidase conjugated antibody (Amersham, Little Chalfont, Buckinghamshire, UK dilution 1/60000). Immunodetection was performed using ECL plus (Amersham) and protein concentration determined using Bradford Protein Assay (BioRad, Hercules, CA, USA).
###end p 74
###begin title 75
Electrophoretic Mobility Shift Assay (EMSA)
###end title 75
###begin p 76
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Wang2">[36]</xref>
###xml 136 163 130 157 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCTTGATGAGTCAGCCGGAA-3&#8242;</named-content>
###xml 258 261 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> 32</sup>
Nuclear extracts prepared as described by Wang et al. [36] were stored at -70degreesC until use. A double-stranded AP-1 oligonucleotide 5'-CGCTTGATGAGTCAGCCGGAA-3' containing a TGAGTCA consensus sequence (Promega, Madison, WI, USA) was end-labeled with gamma 32P-ATP (Amersham) using T4 polynucleotide kinase. AP-1 binding reaction, AP-1 competition assay, and electrophoresis in non-denaturing polyacrylamide gels were performed as described by the manufacturer (Promega).
###end p 76
###begin title 77
Animal Treatment
###end title 77
###begin p 78
###xml 459 464 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 512 543 504 535 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGTTGAAACCCGAGAACATCATGG-3&#8242;</named-content>
###xml 581 612 573 604 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGTACTACAAGAGCCCAAAGTTGCG-3&#8242;</named-content>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
NPcis mice with clear signs of peripheral nerve tumor burden were anesthetized with chloral hydrate (50 microgr/gr animal weight), a cannula (Alzet, Cupertino, CA, USA, Brain Infusion Kit II) was inserted into the right caudate putamen (CP) and connected to a osmotic minipump (Alzet, Model 2004) implanted under the neck skin to ensure continuous administration of the desired solution (350 nmol/7.8 microl DMEM/day, for 28 days). Minipumps were filled with c-fos mRNA Morpholino modified antisense (c-Fos ASO: 5'-GCGTTGAAACCCGAGAACATCATGG-3') or sense oligonucleotide (c-Fos SO: 5'-GGTACTACAAGAGCCCAAAGTTGCG-3') (Gene Tools, Pilomath, OR, USA).
###end p 78
###begin p 79
All experiments were performed in agreement with the standards stated in the Guide to the Care and Use of Experimental Animals published by the Canadian Council on Animal Care and approved by the local animal care committee (Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Argentina, Exp. 15-99-39796).
###end p 79
###begin title 80
Immunohistochemistry
###end title 80
###begin p 81
###xml 280 286 <span type="species:ncbi:9986">rabbit</span>
###xml 344 350 <span type="species:ncbi:9986">rabbit</span>
###xml 495 501 <span type="species:ncbi:9986">rabbit</span>
Anesthetized animals were perfused intracardially with 4% para-formaldehyde/PB 0.1 M. Excised brains and peripheral tumors were immersed in PB 0.1 M/30% sucrose and cryo-sectioned at 30 microm thickness. Sections were blocked in 4% BSA/0.3% Triton X100 in PBS 10 mM, stained with rabbit anti c-Fos (Santacruz Biotechnology, dilution 1/5000) or rabbit anti PCNA (Santacruz Biotechnology, dilution 1/5000) antibodies, diluted in blocking solution for 48 hours at 4degreesC and incubated with anti-rabbit biotinilated secondary antibody diluted in blocking solution (Vector, dilution 1/300) for 1h at room temperature. Detection was performed with the ABC kit (Vector) using DAB (Sigma-Aldrich) as peroxidase substrate. Slides were visualized on an Axiovert-200 (Carl Zeiss, Oberkochen, Germany) microscope and images obtained with a MicroMax CCD camera (Princeton Instruments, Trenton, NJ, USA).
###end p 81
###begin title 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Tumor Samples
###end title 82
###begin p 83
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
Fixed human brain tumor sections and matched benign specimens were from Ambion (Austin, TX, USA). Non-fixed human brain tumor and matched benign specimens were from patients that gave their physicians a written consent on forms approved by the corresponding Research Ethics Board of the Hospital San Roque and Clinica Velez Sarsfield, Cordoba, and MPNST's at Hospital de Clinicas, Buenos Aires, Argentina. Samples were processed anonymous.
###end p 83
###begin title 84
Tissue Immunofluorescence
###end title 84
###begin p 85
###xml 282 288 <span type="species:ncbi:9986">rabbit</span>
###xml 333 337 <span type="species:ncbi:9925">goat</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 458 462 <span type="species:ncbi:9925">goat</span>
###xml 574 578 <span type="species:ncbi:9925">goat</span>
###xml 595 601 <span type="species:ncbi:9986">rabbit</span>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
Specimens were de-waxed in xylene, re-hydrated, treated with target retrieval solution (DakoCytomation, Glostrup, Denmark) at 95degreesC for 30 min and blocked with 1% BSA/0.1% Tween 20 (v/v) in 10 mM PBS (blocking buffer). Primary antibodies diluted in blocking buffer as follows: rabbit anti c-Fos (Sigma-Aldrich, dilution 1/300), goat anti PCNA (Santacruz Biotechnology, dilution 1/300), mouse anti GFAP (Chemicon, Temacula, CA, USA, dilution 1/1000) and goat anti calnexin (Santacruz Biotechnology, dilution 1/300) antibodies were incubated overnight at 4degreesC. Anti goat Alexa 488, anti rabbit Alexa 546 and anti mouse Alexa 688 (Molecular Probes, Eugene, OR, USA) secondary antibodies were applied (dilution 1/500); slides were mounted in Prolong Antifade (Molecular Probes) and visualized on a confocal laser scanning LSM Pascal 5 microscope (Carl Zeiss). LSM 5 Image Browser software was used for image processing.
###end p 85
###begin title 86
Statistical Analysis
###end title 86
###begin p 87
Statistical analysis was performed by Student's two tailed t test using Infostat software (Universidad Nacional de Cordoba, Argentina). Data are reported as mean +/- SD. Differences were considered statistically significant at p<0.005.
###end p 87
###begin title 88
Supporting Information
###end title 88
###begin p 89
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
c-Fos is abundantly expressed and co-localizes with the ER marker calnexin in embryonic mouse brain. Expression of c-Fos (red) and the ER marker calnexin (green) were determined in brain samples from 18 day old embryos and from adult animals. Note c-Fos/ER co-localization as evidenced in the merged image to the right.
###end p 89
###begin p 90
(1.02 MB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009544-Scerbo1">[37]</xref>
###xml 102 106 <span type="species:ncbi:10116">rats</span>
###xml 304 308 <span type="species:ncbi:10116">rats</span>
c-Fos is abundantly expressed and co-localizes with the ER marker calnexin in spinal cord slices from rats with experimental allergic encephalomyelitis. Expression of c-Fos (red), the ER marker calnexin (green) and the reactive gliosis marker GFAP (grey) were determined in spinal cord slices from adult rats with clear symptoms of having developed experimental allergic encephalomyelitis [37] and littermate controls. The last column is the merge of the two first micrographs and clearly shows c-Fos/ER co-localization in the EAE samples that evidence reactive astrocytes as determined by GFAP immunostaining.
###end p 92
###begin p 93
(0.39 MB DOC)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 110 113 <span type="species:ncbi:10116">rat</span>
We thank HJF Maccioni for helpful discussions, I Szijman and RD Del Boca for human sample supply, GA Roth for rat spinal cord sections and Laura Arganaraz for excellent technical support.
###end p 95
###begin title 96
References
###end title 96
###begin article-title 97
The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation.
###end article-title 97
###begin article-title 98
Immediate early genes: ten years on.
###end article-title 98
###begin article-title 99
Immediate early gene expression within the visual system: light and circadian regulation in the retina and the suprachiasmatic nucleus.
###end article-title 99
###begin article-title 100
Leucine zippers of Fos, Jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
###end article-title 100
###begin article-title 101
The Immediate Early Gene c-fos regulates the synthesis of phospholipids but not of gangliosides.
###end article-title 101
###begin article-title 102
Light affects c-Fos expression and phospholipid biosynthesis in both retinal ganglion cells and photoreceptor cells.
###end article-title 102
###begin article-title 103
c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism.
###end article-title 103
###begin article-title 104
c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells.
###end article-title 104
###begin article-title 105
c-Fos activates glucosylceramide synthase and glycolipid synthesis in PC12 cells.
###end article-title 105
###begin article-title 106
N-terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation.
###end article-title 106
###begin article-title 107
Content of endoplasmic reticulum and Golgi complex membranes positively correlates with the proliferative status of brain cells.
###end article-title 107
###begin article-title 108
Integrated endoplasmic reticulum stress responses in cancer.
###end article-title 108
###begin article-title 109
###xml 31 36 <span type="species:ncbi:9606">human</span>
Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
###end article-title 109
###begin article-title 110
Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
###end article-title 110
###begin article-title 111
NF1 tumor suppressor gene function: narrowing the GAP.
###end article-title 111
###begin article-title 112
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
###end article-title 112
###begin article-title 113
Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
###end article-title 113
###begin article-title 114
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of tumor development in neurofibromatosis type 1.
###end article-title 115
###begin article-title 116
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of neurofibromatosis type I: bridging the GAP.
###end article-title 116
###begin article-title 117
The molecular and genetic basis of neurological tumours.
###end article-title 117
###begin article-title 118
Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
###end article-title 118
###begin article-title 119
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system.
###end article-title 119
###begin article-title 120
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration.
###end article-title 120
###begin article-title 121
Pleiotropic effects of a null mutation in the c-fos proto-oncogene.
###end article-title 121
###begin article-title 122
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Bone and haematopoietic defects in mice lacking c-fos.
###end article-title 122
###begin article-title 123
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Fra-1 replaces c-Fos-dependent functions in mice.
###end article-title 123
###begin article-title 124
The hallmarks of cancer.
###end article-title 124
###begin article-title 125
Light stimulation activates retina ganglion cell lysophosphatidic acid acyl transferase and phosphatidic acid phosphatase by a Fos-dependent mechanism.
###end article-title 125
###begin article-title 126
c-Fos is surface active and interacts differentially with phospholipid monolayers.
###end article-title 126
###begin article-title 127
###xml 31 35 <span type="species:ncbi:10116">rats</span>
Gliosis in the spinal cords of rats with allergic encephalomyelitis: immunostaining of carbonic anhydrase and vimentin in reactive astrocytes.
###end article-title 127
###begin article-title 128
Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
###end article-title 128
###begin article-title 129
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.
###end article-title 129
###begin article-title 130
Cytoplasmic functions of the tumour suppressor p53.
###end article-title 130
###begin article-title 131
###xml 53 61 <span type="species:ncbi:9031">chickens</span>
Labeling of retina and optic tectum phospholipids in chickens exposed to light or dark.
###end article-title 131
###begin article-title 132
###xml 32 35 <span type="species:ncbi:10116">rat</span>
The effects of dexamethasone on rat brain cortical nuclear factor kappa B (NF-kappaB) in endotoxic shock.
###end article-title 132
###begin article-title 133
###xml 78 94 <span type="species:ncbi:562">Escherichia coli</span>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
Protective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis.
###end article-title 133
###begin p 134
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 134
###begin p 135
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the James S. McDonnell Foundation (), the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET) ( and ) and SeCyT, Universidad Nacional de Cordoba, Argentina (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 135

